BIOORGANIC CHEMISTRY
21 yayın · 484 atıf
Yayınlar
| Başlık | Yıl | Yazar | Atıf |
|---|---|---|---|
|
Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids
|
2026 | Tokali, Feyzi Sinan, Acar, Ozden Ozgun, Demir, Yeliz +4 | 0 |
|
Design, synthesis,<i> in</i><i> vitro</i> and<i> in</i><i> silico</i> evaluation of thiazole-hydrazine hybrids incorporating an isoindole-1,3-dione scaffold as potent α-glucosidase inhibitors
|
2026 | Aslan, Osman Nuri, Kalin, Seyda Nur, Kalay, Erbay +2 | 0 |
|
Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality
|
2025 | Tokali, Pelin, Demir, Yeliz, Cakir, Furkan +2 | 22 |
|
Synthesis and evaluation of sulfonamide-chalcone hybrid compounds as inhibitors of VEGFR1/VEGFR2-mediated angiogenesis
|
2025 | Barlak, Neslisah, Sanli, Fatma, Celik, Suleyman +7 | 2 |
|
Synthesis of novel benzene bissulfonamides with carbonic anhydrase and choline esterase inhibitory properties
|
2025 | Canoglu, Ugur, Akincioglu, Akin, Oztaskin, Necla +4 | 1 |
|
Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
|
2024 | Gulec, Ozcan, Turkes, Cuneyt, Arslan, Mustafa +5 | 73 |
|
Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies
|
2024 | Soliman, Aya M., Abd El-wahab, Hend A. A., Akincioglu, Hulya +2 | 24 |
|
Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma
|
2024 | Bouzian, Younos, El Hafi, Mohamed, Parvizi, Negar +5 | 3 |
|
Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma
|
2024 | Iqbal, Shazia, Sebhaoui, Jihad, Ashraf, Sajda +10 | 3 |
|
Design, synthesis and anticholinergic properties of novel <i>α</i>-benzyl dopamine, tyramine, and phenethylamine derivatives
|
2024 | Naderi, Ali, Akincioglu, Akin, Cagan, Ahmet +3 | 3 |
|
Design, synthesis, characterization, crystal structure, in silico studies, and inhibitory properties of the PEPPSI type Pd(II)NHC complexes bearing chloro/fluorobenzyl group
|
2023 | Gok, Yetkin, Taslimi, Parham, Sen, Betul +5 | 30 |
|
Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies
|
2022 | Yamali, Cem, Gul, Halise Inci, Sakarya, Mehtap Tugrak +6 | 46 |
|
Selenourea and thiourea derivatives of chiral and achiral enetetramines: Synthesis, characterization and enzyme inhibitory properties
|
2022 | Yigit, Murat, Celepci, Duygu Barut, Taslimi, Parham +5 | 34 |
|
Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores
|
2022 | Yamali, Cem, Sakagami, Hiroshi, Satoh, Keitaro +6 | 14 |
|
Synthesis and aldose reductase inhibition effects of celecoxib derivatives containing pyrazole linked-sulfonamide moiety
|
2022 | Bayrak, Cetin | 10 |
|
Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and α-glycosidase enzymes
|
2021 | Hashmi, Sadaf, Khan, Samra, Shafiq, Zahid +9 | 80 |
|
Synthesis, biological activity and docking calculations of bis-naphthoquinone derivatives from Lawsone
|
2021 | Riaz, Muhammad Tariq, Yaqub, Muhammad, Shafiq, Zahid +6 | 45 |
|
Synthesis, design, and assessment of novel morpholine-derived Mannich bases as multifunctional agents for the potential enzyme inhibitory properties including docking study
|
2021 | Boy, Songul, Turkan, Fikret, Beytur, Murat +4 | 34 |
|
Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An <i>in vitro</i> and <i>in silico</i> study
|
2021 | Celik, Fatih, Turkan, Fikret, Aras, Abdulmelik +4 | 24 |
|
Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel <i>N</i>-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1<i>H</i>-pyrazole-3-carboxamides
|
2021 | Yamali, Cem, Gul, Halise Inci, Ozli, Gulsen +6 | 19 |
|
Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents
|
2021 | Burmaoglu, Serdar, Gobek, Arzu, Aydin, Busra Ozturk +8 | 17 |